Sopharma AD-Sofia (WAR:SPH) Cyclically Adjusted Book per Share: zł11.23 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SPH Sopharma AD-Sofia WAR:SPH
67 GF Score
Price zł7.18
GF Value zł13.30
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia Cyclically Adjusted Book per Share?

Sopharma AD-Sofia WAR:SPH 67 Cyclically Adjusted Book per Share is zł11.23 as of Mar. 2026. GuruFocus rates WAR:SPH with a GF Score™ of 67/100 and a GF Value™ of zł13.30 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sopharma AD-Sofia's adjusted book value per share for the three months ended in Mar. 2026 was zł4.283. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is zł11.23 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sopharma AD-Sofia was 7.80% per year. The lowest was 4.80% per year. And the median was 6.30% per year.

As of today (2026-08-04), Sopharma AD-Sofia's current stock price is zł7.18. Sopharma AD-Sofia's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was zł11.23. Sopharma AD-Sofia's Cyclically Adjusted PB Ratio of today is 0.64.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sopharma AD-Sofia was 3.00. The lowest was 0.65. And the median was 2.22.


Sopharma AD-Sofia  (WAR:SPH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sopharma AD-Sofia's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=7.18/11.23
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sopharma AD-Sofia was 3.00. The lowest was 0.65. And the median was 2.22.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sopharma AD-Sofia Cyclically Adjusted Book per Share Related Terms


Sopharma AD-Sofia Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Cyclically Adjusted Book per Share Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.83 4.64 6.04 5.45 11.93

Sopharma AD-Sofia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.66 5.54 12.38 11.93 11.23

WAR:SPH vs MCK, COR, CAH: Cyclically Adjusted Book per Share Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Cyclically Adjusted PB Ratio falls into.


WAR:SPH
67GF Score
Sopharma AD-Sofia WAR:SPH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma AD-Sofia's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.283/330.2130*330.2130
=4.283

Current CPI (Mar. 2026) = 330.2130.

Sopharma AD-Sofia Quarterly Data

Book Value per Share CPI Adj_Book
201603 6.829 238.132 9.470
201606 7.017 241.018 9.614
201609 7.105 241.428 9.718
201612 7.212 241.432 9.864
201703 7.505 243.801 10.165
201706 7.871 244.955 10.611
201709 8.481 246.819 11.347
201712 8.444 246.524 11.311
201803 9.002 249.554 11.912
201806 8.408 251.989 11.018
201809 8.416 252.439 11.009
201812 8.203 251.233 10.782
201903 8.459 254.202 10.988
201906 8.563 256.143 11.039
201909 8.543 256.759 10.987
201912 9.389 256.974 12.065
202006 9.687 257.797 12.408
202009 10.037 260.280 12.734
202012 10.215 260.474 12.950
202103 0.000 264.877 0.000
202106 10.681 271.696 12.981
202109 10.896 274.310 13.117
202112 11.463 278.802 13.577
202203 11.508 287.504 13.218
202206 11.424 296.311 12.731
202209 11.052 296.808 12.296
202212 11.681 296.797 12.996
202303 12.400 301.836 13.566
202306 11.882 305.109 12.860
202309 12.017 307.789 12.892
202312 9.699 306.746 10.441
202403 10.430 312.332 11.027
202406 9.943 314.175 10.451
202409 10.434 315.301 10.927
202412 9.864 315.605 10.321
202503 10.699 319.799 11.047
202506 11.540 322.561 11.814
202509 4.110 324.800 4.178
202512 4.026 324.054 4.103
202603 4.283 330.213 4.283

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of zł11.23 mean?
Sopharma AD-Sofia (WAR:SPH) has a Cyclically Adjusted Book per Share of zł11.23 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors.
Is Sopharma AD-Sofia's Cyclically Adjusted Book per Share too high?
Sopharma AD-Sofia's current Cyclically Adjusted Book per Share is zł11.23. Overall, Sopharma AD-Sofia has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Cyclically Adjusted Book per Share compare to MCK and COR?
Sopharma AD-Sofia's Cyclically Adjusted Book per Share of zł11.23 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Distribution company?
A good Cyclically Adjusted Book per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors. Sopharma AD-Sofia's current Cyclically Adjusted Book per Share is zł11.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (WAR:SPH) is currently considered Possible Value Trap. The stock's GF Value™ is zł13.30, compared to a current price of zł7.18 — trading 46% below its estimated fair value. The current Cyclically Adjusted Book per Share is zł11.23. Sopharma AD-Sofia's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sopharma AD-Sofia (WAR:SPH), the current Cyclically Adjusted Book per Share is zł11.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma AD-Sofia (WAR:SPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of zł7.18 is trading 46% below its estimated GF Value™ of zł13.30. GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.

Key valuation signals for WAR:SPH:

  • Cyclically Adjusted Book per Share: zł11.23
  • GF Value™: zł13.30 vs. price of zł7.18 (46% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the WAR:SPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma AD-Sofia Business Description

Other Exchanges 3JR:GermanySFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
67GF Score

Get the complete analysis for WAR:SPH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł7.18
Price
zł13.30
GF Value